Agius MA, Kirvan CA,
Schafer
AL, Gudipati E., Zhu
S.High prevalence of anti-α-crystallin
antibodies in multiple sclerosis: Correlation with severity and activity of
disease. Acta Neurol Scand1999;
100: 139-147.
2.
Antel JP, Bania MB,
Reder
A., Cashman N.Activated
suppressor cell dysfunction in progressive multiple sclerosis .
J Immunol1986;
137-141.
3.
Bashir K., Whitaker
JNClinical and laboratory features of
primary progressive and secondary progressive MS.
Neurology1999; 53:
765-771.
4.
Birnbaum G., Lackovic V.,
Kotilinek
L., Tobolt D.A comparison of
regulatory cells in spinal fluid and blood in patients with multiple sclerosis and other
neurologic diseases. Neurology1990;
40: 1785-1790.
5.
Brosnan CF, Cannella B.,
Battistini
L., Raine CSCytokine
localization in multiple sclerosis lesions: Correlation with adhesion molecule
expression and reactive nitrogen species.
Neurology1995; 45(Suppl
6): S16-S21.
6.
Correale J., Gilmore W.,
Lopez
J., McMillan M., Weiner
LPDefective post-thymic tolerance mechanisms
during the chronic progressive stage of multiple sclerosis.
Nature Med1996 ; 2:
1354-1360.
7.
Correale J., Rojany M.,
Weiner
LPHuman CD8+, TCR-αβ+ and TCR-γδ+ cells
modulate autologous autoreactive neuroantigens-specific CD4+T-cells by different
mechanisms. J Neuroimmunol1997;
80: 47-64.
8.
Correale J., McMillan M.,
Li
S., McCarthy K., Le T.,
Weiner
JPAntigen presentation by autoreactive
proteolipid protein peptide-specific cell clones from chronic progressive multiple
sclerosis patients: Roles of co-stimulatory B7 molecules and IL-12.
J Neuroimmunol1997; 72:
27-43.
9.
Correale J., Lund B.,
McMillan
M., Ko, DY, McCarthy K.,
Weiner
LPT cell vaccination in secondary
progressive multiple sclerosis. J
Neuroimmunol2000; 107:
130-139.
10.
Correale J., Gilmore W.,
Li
S., Walsh J., Bassani MM,
Lund
B., Arias M., Weiner
LPResistance of glucocorticoid-induced
apoptosis in PLP peptide-specific T cell clones from patients with progressive
MS. J Neuroimmunol2000;
109: 197-210.
11.
Crucian B., Dunne P.,
Friedman
H., Ragsdale R., Pross S.,
Widen
R.Alterations in levels of CD28-/CD8+
suppressor cell precursors and CD45RO+/CD4+ memory T lymphocytes in peripheral blood of
multiple sclerosis patients. Clin Diag Lab
Immunol1995; 2:
249-252.
12.
Gallo P., Piccinno MG,
Tavolato
B., Siden A.A longitudinal study
on IL-2, sIL-2R, IL-4 and IFN-γ in multiple sclerosis CSF and serum.
J Neurol Sci1991 ; 101:
227-232.
13.
Goebels N., Hofstetter H.,
Schmidt
S., Brunner C., Wekerle H.,
Hohlfeld
R.Repertoire dynamics of autoreactive T
cells in multiple sclerosis patients and health subjects. Epitope spreading versus
clonal persistence . Brain2000;
123: 508-518.
14.
Hafler DA, Weiner
HLMS: A CNS and systemic autoimmune
disease. Immunol Today10:
104-107.
15.
Hauser SL, Doolittle TH,
Lincoln
R., Brown RH, Dinarello
CACytokine accumulations in CSF of multiple
sclerosis patients: Frequent detection of interleukin-1 and tumor necrosis factor but
not interleukin-6 . Neurology1990;
40: 1735-1739.
16.
Hvas J., Oksenberg JR,
Fernando
R., Steinman L., Bernard
Cca.γδ T cell receptor repertoire in brain
lesions of patients with multiple sclerosis.
JNeuroimmunol1993 ; 46:
225-234.
17.
Jurewicz AM , Walczak AK,
Selmaj
KWShedding of TNF receptors in multiple
sclerosis patients. Neurology1999;
53: 1409-1414.
18.
Lovett-Racke AE, Martin R.,
McFarland
HF, Racke MK, Utz
U.Longitudinal study of myelin basic
protein-specific T-cell receptors during the course of multiple
sclerosis. J Neuroimmunol1997 ;
78: 162-171.
19.
Openshaw H. , Stuve O.,
Antel
JP, Nash R., Lund BT,
Weiner
LP, Kashyap A., McSweeney P.,
Forman
S.Multiple sclerosis flares associated with
recombinant granulocyte colony-stimulating factor.
Neurology2000; 54:
2147-2150.
20.
Selmaj K., Brosnan CF,
Raine
CSColocalization of lymphocytes bearing γδ
T-cell receptor and heat shock protein hsp65+ oligodendrocytes in multiple
sclerosis. Proc Nat Acad Sci1991;
88: 6452-6456.
21.
Stinissen P. , Raus J.,
Zhang
J.Autoimmune pathogenesis of multiple
sclerosis: Role of autoreactive T lymphocytes and new immunotherapeutic
strategies . Crit Rev in Immunol1997;
17: 33-75.
22.
Trapp BD, Ransohoff R.,
Rudick
R.Axonal pathology in multiple sclerosis:
Relationship to neurologic disability. Curr Opin in
Neurol1999; 12:
295-302.
23.
Trotter JL, Collins KG, van der
Veen
RCSerum cytokine levels in chronic
progressive multiple sclerosis: Interleukin-2 levels parallel tumor necrosis factor-α
levels. J Neuroimmunol1991;
33: 29-36.
